Pacific Yew.
Pacific yew is a tree rather than a supplement material. Its needles and seeds carry taxine alkaloids that block cardiac sodium and calcium channels, so the plant is poisonous.
- Category
- Herb
What Pacific Yew is, and what it does.
- Does it work
- This one is for readers checking a label out of curiosity. The tree's real role is as controlled pharmaceutical feedstock, which is a different thing from the plant.
- How much to take
- No amount is on record, and none should be. There is no established intake for yew plant material, and the taxine alkaloid content is exactly why.
- Time to feel it
- There is no supplemental use to put a timeline on. Where yew plant material has been swallowed, taxine effects come on within hours.
- The first dose
- There is no ordinary day one here. Swallowing needles or seeds is a poisoning event, and what the literature holds are emergency case reports.
- With regular use
- Nobody has studied long-term intake of yew plant material in people, and the taxine content is why nobody will. The tree's ongoing role is as a source of purified compounds.
- How well tolerated
- The plant is toxic. Taxine alkaloids in needles and seeds disrupt cardiac conduction, and any suspected ingestion is an emergency rather than something to watch.
- How it feels
- There is no benign subjective experience to report. Case reports describe nausea, dizziness and a disturbed heartbeat after ingestion.
- The overlooked benefit
- Taking needles instead of bark for the semi-synthetic starting material lets the tree survive the harvest, which changed the whole supply picture for these compounds.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- cardiac conduction failure from taxine alkaloidsNarrative review
- renewable needle feedstock for semi-synthetic taxane productionNarrative review
- taxane handling by CYP3A4, CYP2C8 and P-glycoproteinNarrative review
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Taxane diterpenes from yew are cleared through CYP3A4 and CYP2C8. Piperine inhibits CYP3A4 and intestinal efflux, which raises exposure to substrates of that enzyme. With a compound class this narrow in margin, raised exposure is a hazard rather than a benefit. This row exists as a warning, not a pairing.
Hypericum induces CYP3A4 strongly and lowers plasma levels of taxane-class drugs, an interaction documented in oncology pharmacology. The direction is loss of exposure. Anyone on a taxane medicine has a clinically meaningful reason to avoid this combination and should raise it with their prescriber.
Silymarin inhibits UGT and, at higher concentrations, CYP3A4 in laboratory systems, both of which handle taxanes. Human pharmacokinetic work on the combination is limited and inconsistent. The plausible direction is altered taxane clearance, which is why it belongs on a caution list rather than a stack.
Nothing specific on file for Pacific Yew. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Pacific Yew actually does.
The needles and seeds contain heart poisons. That is a separate matter from the purified drug made from the bark.
Drug makers now start from a compound in the needles instead of stripping bark, so the trees survive.
Taxane compounds are processed by specific liver enzymes and a transport protein, so anything that speeds up or slows down those routes can shift how much taxane the body is exposed to.
Where Pacific Yew comes from.
Pacific yew is a tree, and it is where an important chemotherapy drug came from. The tree itself is poisonous. The medicine is a purified extract made under pharmaceutical control, which is not the same thing as the plant.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
A slow-growing understory conifer of the Pacific Northwest. Its slow growth is why bark harvesting was never sustainable at pharmaceutical scale.
Historically bark was solvent extracted for paclitaxel directly. Current routes extract 10-deacetylbaccatin III from needles, which regrow.
10-DAB III is chemically converted to paclitaxel or docetaxel through side-chain attachment and protection or deprotection steps.
Taxanes are separated from taxine alkaloids and related diterpenes. This separation is what makes the pharmaceutical distinct from the plant.
Delivered as a prescription injectable, not as a dietary ingredient.
The forms it comes in.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.